Natasja Franceschini

Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression

A. Cleton-Jansen, A. Kruisselbrink, J. Bovée, 2021, International journal of molecular sciences.

What’s new in bone forming tumours of the skeleton?

A. Cleton-Jansen, J. Bovée, Suk Wai Lam, 2019, Virchows Archiv.

Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics

A. Cleton-Jansen, H. Baelde, M. Tryfonidou, 2021, Cancers.

A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target

A. Cleton-Jansen, A. Kruisselbrink, J. Bovée, 2021, Laboratory Investigation.

WNT/beta-catenin signalling interrupts a senescence-induction cascade in human mesenchymal stem cells that restricts their expansion

P. D. de Keizer, D. Drabek, G. V. van Osch, 2022, Cellular and Molecular Life Sciences.

Bone: Conventional Osteosarcoma

A. Cleton-Jansen, J. Bovée, Natasja Franceschini, 2019, Atlas of Genetics and Cytogenetics in Oncology and Haematology.